October 2, 2024 12:35 PM EDT
Health Tech

A blow to Hu­mana’s Medicare Ad­van­tage qual­i­ty rat­ings could tank its rev­enue by bil­lions

Shelby Livingston

Senior health tech reporter

Af­ter an al­ready bru­tal year for its Medicare Ad­van­tage busi­ness, ma­jor health in­sur­er Hu­mana said it’s tak­en a hit to its health plan qual­i­ty rat­ings …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

Lil­ly in­vests $4.5B in new In­di­ana site to bring clin­i­cal man­u­fac­tur­ing in-house

Ex­clu­sive: Af­ter dis­cov­er­ing an­tibi­otics with AI, a 31-year-old first-time CEO rais­es $17M to fight ag­ing

Scoop: Found­ing CEO leaves Atom­wise, cast­ing doubt over a once high-fly­ing AI start­up 

Fra­zier adds $630M to pub­lic fund to 'take ad­van­tage of mar­ket volatil­i­ty'

UK biotech bags $43M in Se­ries A to move Hunt­ing­ton's drug in­to first hu­man study

sponsored

3 Tiers for AAV Po­ten­cy As­say De­vel­op­ment Suc­cess

A service from the Financial Times